Archive for Author: WBMA

ESKETAMINE (SPRAVATO™) 101

In March 2019, the Food and Drug Administration approved esketamine (SPRAVATO™) nasal spray to be used in conjunction with an oral antidepressant, for the treatment of treatment-resistant depression (TRD) in adults.¹ TRD affects almost one-third of patients with depression...

Read More

Peer review

Over the years I have noticed that consumers have a very difficult time understanding the quality of a scientific report, whether it is a book, a magazine or journal article. Scientific knowledge is based on incremental progress derived from...

Read More

Welcome to Research In Plain English

The objective of Research In Plain English is to provide an unbiased review of recent biomedical research publications in the areas of psychopharmacology, psychiatry, child psychiatry, intellectual disabilities, autism and genetic disorders. I will pick articles that are of...

Read More